Clinical Trials in Houston

Showing 5761-5780 of 17,885 trials

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

NCT00178594

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.

Blood Coagulation Disorders, InheritedThrombotic Disorder

The University of Texas Health Science Center, Houston1,000 participantsStarted Oct 2002

Houston, Texas, United States • Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study of TAK-861 in Participants With Narcolepsy Type 2

NCT05687916

The main aim is to evaluate the effect of TAK-861 on symptoms of narcolepsy, including excessive daytime sleepiness (EDS) as measured by sleep latency from the Maintenance of Wakefulness Test (MWT). The study will enroll approximately 60 participants and they will be randomly assigned to 3 groups (20 per group) to take one of two different doses of TAK-861 or a placebo. All the participants will receive the treatment for 8 weeks. Participants will be asked to complete some questionnaires during the study. This trial will be conducted in North America, Europe, and Asia Pacific.

Narcolepsy Type 2

Takeda71 participantsStarted Jan 2023

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Redwood City, California, United States +53 more locations

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

A Study of TAK-861 in Participants With Narcolepsy Type 2

Find Trials by Condition in Houston

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

Benefits of µCor in Ambulatory Decompensated Heart Failure

An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors

Dextrose Gel Does Not Prevent Neonatal Hypoglycemia

AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis

A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities

Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer